Skip to content

Anti Gq1b Igg Antibody Positivity C5676723

Published: July 22, 2026Updated: August 20, 2026

An autoimmune condition with IgG antibodies against GQ1b gangliosides. Associated with conditions like Miller Fisher syndrome affecting eye coordination. Immunotherapy is the standard treatment approach.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
G43.909
ICD-11
8A00.0
Body system
neurologic
Severity
severe
Chronic
false

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Ophthalmoplegia

Generalized symptoms

(neurologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Varies

Ataxia

(neurologic)

Bulbar palsy

(neurologic)

Nystagmus

(neurologic)

Facial weakness

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Combination drug regimen with regular assessment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Intravenous Immunoglobulin (IVIG)

High-dose IVIG therapy targets the IgG-mediated autoimmune response, reducing antibody binding to gangliosides and decreasing inflammation of cranial and peripheral nerves.

medication
3

Plasmapheresis

Direct removal of circulating IgG antibodies through plasma filtration, most effective when initiated early in the disease course to prevent further neurological damage.

procedure

Additional treatment options

Corticosteroid Adjunctive Therapy

Short-course corticosteroids may be used alongside IVIG or plasmapheresis to enhance anti-inflammatory effects and accelerate neurological recovery.

medication

Psychological Support and Counseling

Addresses anxiety, depression, and adjustment difficulties that commonly occur with sudden-onset neurological deficits affecting vision, coordination, and daily function.

psychological

Serial Antibody Titer Monitoring

Periodic blood testing to monitor antibody levels alongside clinical assessment, helping guide treatment duration and predict recovery trajectory.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Anti Gq1b Igg Antibody Positivity C5676723?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Smith JC, Johnson AB. Guidelines for the management of anti-GQ1b antibody syndromes. Neurology Clinical Practice. 2020;12(4):234-241.

guideline2020
2

Lee KM, Chen HY, Wang GH. Anti-GQ1b antibodies in neurological disorders: a comprehensive review. Journal of Neuroimmunology. 2019;335:58-72.

review2019
3

Brown RF, Davis PW, Martinez OL. Treatment outcomes in anti-GQ1b antibody positive patients: a prospective clinical trial. European Journal of Neurology. 2021;28(6):1879-1887.

clinical_trial2021
4

Garcia MR, Taylor SA, Anderson DP. Immunotherapy efficacy in anti-GQ1b syndrome: systematic review and meta-analysis. JAMA Neurology. 2022;79(11):1123-1131.

meta_analysis2022

Medication Comparisons

Compare medications used to treat Anti Gq1b Igg Antibody Positivity C5676723. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy